1
|
Sheibani L, McKenzie-Howat E, Shafi N, Watson D. P165 Exploring weight change and subjective experiences on Kaftrio® in adults with cystic fibrosis. J Cyst Fibros 2022. [DOI: 10.1016/s1569-1993(22)00496-9] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/28/2022]
|
2
|
Sheibani L, Dunnage M, Shafi N, Watson D. 21: Review of glycaemic control, nutritional status and lung function after initiation of flash glucose monitoring for patients with cystic fibrosis–related diabetes. J Cyst Fibros 2021. [DOI: 10.1016/s1569-1993(21)01446-6] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/20/2022]
|
3
|
Sheibani L, Raymond K, Rugarn O, Wing DA. Associations of hypertensive disorders of pregnancy and outcomes of labor induction with prostaglandin vaginal inserts. Hypertens Pregnancy 2018; 37:51-57. [PMID: 29291357 DOI: 10.1080/10641955.2017.1420800] [Citation(s) in RCA: 3] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/12/2022]
Abstract
OBJECTIVE To evaluate the association between hypertensive (HTNsive) disorders of pregnancy and outcomes of labor induction, in two cohorts of women induced with either misoprostol vaginal insert (MVI) or dinoprostone vaginal insert (DVI). STUDY DESIGN This investigation was a post-hoc analysis of data from three Phase II and III, multi-center, double blind, randomized controlled trials of women induced with identical efficacy endpoints. A competing risk framework investigated the association between HTNsive disorders of pregnancy and the time-to-event endpoints of onset of active labor and vaginal delivery. We analyzed the overall incidence of the competing risk, cesarean delivery, by logistic regression to identify potential differences between the proportion of patients with cesarean and vaginal deliveries for each cohort. RESULTS 401 women with HTNsive disorders during pregnancy underwent induction of labor in these studies (175 with DVI and 226 with MVI). Significant differences were noted in the cumulative incidence of vaginal delivery 24 hours following insertion between the non-HTNsive and HTNsive groups for both treatments, (57.1% vs. 47.4% (p=0.023) among MVI patients and 39.9% vs. 27.2% (p=0.017) among DVI patients). However, upon adjusting for potential confounders, the estimated relative rates of vaginal delivery among HTNsive vs. non-HTNsive patients was 0.947 (95% CI (0.637, 1.371), p=0.631) and 0.904 (95% CI (0.735, 1.113) p=0.341) within the MVI and DVI sub-groups respectively. CONCLUSION After adjustment for confounders, such as BMI, baseline modified Bishop score and gestational age, time-to-event outcomes for induction of labor using MVI or DVI in HTNsive women are not significantly different from non-HTNsive women.
Collapse
Affiliation(s)
- Lili Sheibani
- a Division of Maternal-Fetal Medicine, Department of Obstetrics & Gynecology , University of California Irvine Medical Center , Orange , CA , USA
| | - Kyle Raymond
- b Ferring Pharmaceuticals , Copenhagen , Denmark
| | - Olof Rugarn
- b Ferring Pharmaceuticals , Copenhagen , Denmark
| | - Deborah A Wing
- a Division of Maternal-Fetal Medicine, Department of Obstetrics & Gynecology , University of California Irvine Medical Center , Orange , CA , USA
| |
Collapse
|
4
|
Sheibani L, Lechuga TJ, Zhang H, Hameed A, Wing DA, Kumar S, Rosenfeld CR, Chen DB. Augmented H2S production via cystathionine-beta-synthase upregulation plays a role in pregnancy-associated uterine vasodilation. Biol Reprod 2017; 96:664-672. [PMID: 28339573 DOI: 10.1095/biolreprod.116.143834] [Citation(s) in RCA: 39] [Impact Index Per Article: 5.6] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/28/2016] [Accepted: 01/17/2017] [Indexed: 01/07/2023] Open
Abstract
Endogenous hydrogen sulfide (H2S) synthesized via metabolizing L-cysteine by cystathionine-beta-synthase (CBS) and cystathionine-gamma-lyase (CSE) is a potent vasodilator and angiogenic factor. The objectives of this study were to determine if human uterine artery (UA) H2S production increases with augmented expression and/or activity of CBS and/or CSE during the menstrual cycle and pregnancy and whether exogenous H2S dilates UA. Uterine arteries from nonpregnant (NP) premenopausal proliferative (pPRM) and secretory (sPRM) phases of the menstrual cycle and pregnant (P) women were studied. H2S production was measured by the methylene blue assay. CBS and CSE mRNAs were assessed by quantitative real-time PCR, and proteins were assessed by immunoblotting and semiquantitative immunofluorescence microscopy. Effects of H2S on rat UA relaxation were determined by wire myography ex vivo. H2S production was greater in NP pPRM and P than NP sPRM UAs and inhibited by the specific CBS but not CSE inhibitor. CBS but not CSE mRNA and protein were greater in NP pPRM and P than NP sPRM UAs. CBS protein was localized to endothelium and smooth muscle and its levels were in a quantitative order of P >NP UAs of pPRM>sPRM. CSE protein was localized in UA endothelium and smooth muscle with no difference among groups. A H2S donor relaxed P > NP UAs but not mesentery artery. Thus, human UA H2S production is augmented with endothelium and smooth muscle CBS upregulation, contributing to UA vasodilation in the estrogen-dominant physiological states in the proliferative phase of the menstrual cycle and pregnancy.
Collapse
Affiliation(s)
- Lili Sheibani
- Department of Obstetrics and Gynecology, University of California Irvine, Irvine, California, USA
| | - Thomas J Lechuga
- Department of Obstetrics and Gynecology, University of California Irvine, Irvine, California, USA
| | - Honghai Zhang
- Department of Obstetrics and Gynecology, University of California Irvine, Irvine, California, USA
| | - Afshan Hameed
- Department of Obstetrics and Gynecology, University of California Irvine, Irvine, California, USA
| | - Deborah A Wing
- Department of Obstetrics and Gynecology, University of California Irvine, Irvine, California, USA
| | - Sathish Kumar
- Department of Obstetrics and Gynecology, University of Texas Medical Branch-Galveston, Galveston, Texas, USA
| | - Charles R Rosenfeld
- Department of Pediatrics and Obstetrics and Gynecology, University of Texas Southwestern Medical School, Dallas, Texas, USA
| | - Dong-Bao Chen
- Department of Obstetrics and Gynecology, University of California Irvine, Irvine, California, USA
| |
Collapse
|
5
|
Affiliation(s)
- Lili Sheibani
- Obstetrics and Gynecology, Keck School of Medicine of the University of Southern California, Los Angeles, CA, USA
| | - Deborah A. Wing
- Obstetrics & Gynecology, University of California Irvine School of Medicine, Orange, CA, USA
| |
Collapse
|
6
|
Zhang HH, Chen JC, Sheibani L, Lechuga TJ, Chen DB. Pregnancy Augments VEGF-Stimulated In Vitro Angiogenesis and Vasodilator (NO and H2S) Production in Human Uterine Artery Endothelial Cells. J Clin Endocrinol Metab 2017; 102:2382-2393. [PMID: 28398541 PMCID: PMC5505189 DOI: 10.1210/jc.2017-00437] [Citation(s) in RCA: 23] [Impact Index Per Article: 3.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 02/15/2017] [Accepted: 04/03/2017] [Indexed: 11/19/2022]
Abstract
CONTEXT Augmented uterine artery (UA) production of vasodilators, including nitric oxide (NO) and hydrogen sulfide (H2S), has been implicated in pregnancy-associated and agonist-stimulated rise in uterine blood flow that is rate-limiting to pregnancy health. OBJECTIVE Developing a human UA endothelial cell (hUAEC) culture model from main UAs of nonpregnant (NP) and pregnant (P) women for testing a hypothesis that pregnancy augments endothelial NO and H2S production and endothelial reactivity to vascular endothelial growth factor (VEGF). DESIGN Main UAs from NP and P women were used for developing hUAEC culture models. Comparisons were made between NP- and P-hUAECs in in vitro angiogenesis, activation of cell signaling, expression of endothelial NO synthase (eNOS) and H2S-producing enzymes cystathionine β-synthase (CBS) and cystathionine γ-lyase, and NO/H2S production upon VEGF stimulation. RESULTS NP- and P-hUAECs displayed a typical cobblestone-like shape in culture and acetylated low-density lipoprotein uptake, stained positively for endothelial and negatively for smooth muscle markers, maintained key signaling proteins during passage, and had statistically significant greater eNOS and CBS proteins in P- vs NP-hUAECs. Treatment with VEGF stimulated in vitro angiogenesis and eNOS protein and NO production only in P-hUEACs and more robust cell signaling in P- vs NP-hUAECs. VEGF stimulated CBS protein expression, accounting for VEGF-stimulated H2S production in hUAECs. CONCLUSION Comparisons between NP- and P-hUAECs reveal that pregnancy augments VEGF-stimulated in vitro angiogenesis and NO/H2S production in hUAECs, showing that the newly established hUAEC model provides a critical in vitro tool for understanding human uterine hemodynamics.
Collapse
Affiliation(s)
- Hong-hai Zhang
- Department of Obstetrics & Gynecology, University of California, Irvine, California 92697
| | - Jennifer C. Chen
- Department of Obstetrics & Gynecology, University of California, Irvine, California 92697
| | - Lili Sheibani
- Department of Obstetrics & Gynecology, University of California, Irvine, California 92697
| | - Thomas J. Lechuga
- Department of Obstetrics & Gynecology, University of California, Irvine, California 92697
| | - Dong-bao Chen
- Department of Obstetrics & Gynecology, University of California, Irvine, California 92697
| |
Collapse
|
7
|
Sheibani L, Gabby LC, Westermann M, Steller J, Khosravi D, Portnoy D, Hameed AB. 958: Can noninvasive continuous hemodynamic monitoring reliably differentiate preeclampsia from the normotensive state? Am J Obstet Gynecol 2017. [DOI: 10.1016/j.ajog.2016.11.867] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/24/2022]
|
8
|
Sheibani L, Fong A, Henry DE, Norton ME, Truong YN, Anyikam A, Laurent LC, Rao R, Wing DA. Maternal and neonatal outcomes after antenatal corticosteroid administration for PPROM at 32 to 33 6/7 weeks gestational age. J Matern Fetal Neonatal Med 2016; 30:1676-1680. [DOI: 10.1080/14767058.2016.1222366] [Citation(s) in RCA: 3] [Impact Index Per Article: 0.4] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/21/2022]
Affiliation(s)
- Lili Sheibani
- University of California, Irvine Health, Orange, CA, USA,
| | - Alex Fong
- University of California, Irvine Health, Orange, CA, USA,
| | - Dana E. Henry
- University of California, San Francisco, Medical Center, San Francisco, CA, USA,
| | - Mary E. Norton
- University of California, San Francisco, Medical Center, San Francisco, CA, USA,
| | - Yen N. Truong
- University of California, Davis, Medical Center, Sacramento, CA, USA,
| | - Adanna Anyikam
- University of California, San Diego Medical Center, San Diego, CA, USA, and
| | - Louise C. Laurent
- University of California, San Diego Medical Center, San Diego, CA, USA, and
| | - Rashmi Rao
- University of California, Los Angeles, Medical Center, Los Angeles, CA, USA
| | | | | |
Collapse
|
9
|
Chen D, Lechuga T, Sheibani L, Amanpreet B, Zhang H. 18 Hydrogen sulfide stimulates human myometrial angiogenesis: Influence of endogenous estrogens. Pregnancy Hypertens 2016. [DOI: 10.1016/j.preghy.2016.08.019] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/16/2022]
|
10
|
Sheibani L, Lechuga TJ, Zhang HH, Wing DA, Chen DB. 828: H2S biosynthesis is increased during pregnancy in association with augmented cystathionine β-synthase expression. Am J Obstet Gynecol 2016. [DOI: 10.1016/j.ajog.2015.10.878] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/28/2022]
|
11
|
Abstract
INTRODUCTION Induction of labor remains one of the most commonly performed procedures in the US and in other developed countries around the world. Various agents for cervical ripening are used prior to induction; the most commonly used are prostaglandins and oxytocin. The ideal agent is one that decreases time to vaginal delivery without compromising maternal and/or fetal safety. AREAS COVERED This article reviews the current pharmacologic methods available for induction of labor. Although these agents have been extensively studied and their safety and efficacy profile are well accepted, there is still ongoing research to determine the safest and most effective method. The article discusses the impact of pharmacogenomics as it relates to the most common induction agents. The dosing, route of administration, and side effects of these agents are reviewed. EXPERT OPINION Prostaglandins and oxytocin have been proven to be safe and effective methods of induction. However, the optimal medication for induction is yet to be determined. Although there are currently no pharmacogenomic findings that affect dosing of either prostaglandins or oxytocin, this is a growing area of research. In the near future, it may become clear that there is no 'one regimen for all' when selecting an induction or cervical ripening agent, or any other pharmaceutical altogether.
Collapse
Affiliation(s)
- Deborah A Wing
- University of California Irvine School of Medicine - Obstetrics & Gynecology , 101 The City Drive Building 56 800, Orange, CA 92868 , USA +1 714 456 5967 ; +1 714 456 8383 ;
| | | |
Collapse
|
12
|
Lechuga TJ, Zhang HH, Sheibani L, Karim M, Jia J, Magness RR, Rosenfeld CR, Chen DB. Estrogen Replacement Therapy in Ovariectomized Nonpregnant Ewes Stimulates Uterine Artery Hydrogen Sulfide Biosynthesis by Selectively Up-Regulating Cystathionine β-Synthase Expression. Endocrinology 2015; 156:2288-98. [PMID: 25825818 PMCID: PMC4430606 DOI: 10.1210/en.2015-1086] [Citation(s) in RCA: 35] [Impact Index Per Article: 3.9] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 01/23/2023]
Abstract
Estrogens dramatically dilate numerous vascular beds with the greatest response in the uterus. Endogenous hydrogen sulfide (H2S) is a potent vasodilator and proangiogenic second messenger, which is synthesized from L-cysteine by cystathionine β-synthase (CBS) and cystathionine γ-lyase (CSE). We hypothesized that estrogen replacement therapy (ERT) selectively stimulates H2S biosynthesis in uterine artery (UA) and other systemic arteries. Intact and endothelium-denuded UA, mesenteric artery (MA), and carotid artery (CA) were obtained from ovariectomized nonpregnant ewes (n = 5/group) receiving vehicle or estradiol-17β replacement therapy (ERT). Total RNA and protein were extracted for measuring CBS and CSE, and H2S production was determined by the methylene blue assay. Paraffin-embedded UA rings were used to localize CBS and CSE proteins by immunofluorescence microscopy. ERT significantly stimulated CBS mRNA and protein without altering CSE mRNA or protein in intact and denuded UA. Quantitative immunofluorescence microscopic analyses showed CBS and CSE protein localization in endothelium and smooth muscle and confirmed that ERT stimulated CBS but not CSE protein expression in UA endothelium and smooth muscle. ERT also stimulated CBS, but not CSE, mRNA and protein expression in intact and denuded MA but not CA in ovariectomized ewes. Concomitantly, ERT stimulated UA and MA but not CA H2S production. ERT-stimulated UA H2S production was completely blocked by a specific CBS but not CSE inhibitor. Thus, ERT selectively stimulates UA and MA but not CA H2S biosynthesis by specifically up-regulating CBS expression, implicating a role of H2S in estrogen-induced vasodilation and postmenopausal women's health.
Collapse
Affiliation(s)
- Thomas J Lechuga
- Departments of Obstetrics and Gynecology (T.J.L., H.H.Z., L.S., M.K., J.J., D.-b.C.) and Pathology (T.J.L., D.-b.C.), University of California Irvine, Irvine, California 92697; Department of Obstetrics and Gynecology, Pediatrics, and Animal Sciences (R.R.M.), University of Wisconsin-Madison, Madison, Wisconsin 53715; and Division of Neonatal-Perinatal Medicine (C.R.R.), Department of Pediatrics and Obstetrics and Gynecology, University of Texas Southwestern Medical Center, Dallas, Texas 75390
| | | | | | | | | | | | | | | |
Collapse
|
13
|
Sheibani L, Fong A, Henry D, Norton M, Truong Y, Anyikam A, Laurent L, Rao R, Wing D. 349: Maternal and neonatal outcomes after antenatal corticosteroid administration for PPROM at 32-33 6/7 weeks gestational age. Am J Obstet Gynecol 2015. [DOI: 10.1016/j.ajog.2014.10.395] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/24/2022]
|
14
|
Affiliation(s)
- L Sheibani
- Department of Obstetrics & Gynecology, University of California, Irvine, CA, USA
| | | |
Collapse
|
15
|
|
16
|
Abstract
Intrahepatic cholestasis (ICP) of pregnancy is a disease that is likely multifactorial in etiology and has a prevalence that varies by geography and ethnicity. The diagnosis is made when patients have a combination of pruritus and abnormal liver-function tests. It is associated with a high risk for adverse perinatal outcome, including preterm birth, meconium passage, and fetal death. As of yet, the cause for fetal death is unknown. Because fetal deaths caused by ICP appear to occur predominantly after 37 weeks, it is suggested to offer delivery at approximately 37 weeks. Ursodeoxycholic acid appears to be the most effective medication to improve maternal pruritus and liver-function tests; however, there is no medication to date that has been shown to reduce the risk for fetal death.
Collapse
Affiliation(s)
- Bhuvan Pathak
- Division of Maternal Fetal Medicine, Department of Obstetrics and Gynecology, University of Southern California, 2020 Zonal Avenue, IRD, Room 203, Los Angeles, CA 90033, USA
| | | | | |
Collapse
|
17
|
Melkonyan A, Sheibani L, Chase D, Tewari K. Adenocarcinoma versus adenosquamous carcinoma of the cervix: A comparison of diagnostic, clinical and pathological outcomes. Gynecol Oncol 2010. [DOI: 10.1016/j.ygyno.2009.10.002] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/28/2022]
|